当前位置: X-MOL 学术Hypertension › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Animal Models of Preeclampsia
Hypertension ( IF 6.9 ) Pub Date : 2020-06-01 , DOI: 10.1161/hypertensionaha.119.14598
Kathryn L Gatford 1 , Prabha H Andraweera 1 , Claire T Roberts 1 , Alison S Care 1
Affiliation  

Supplemental Digital Content is available in the text. Preeclampsia is a common pregnancy complication, affecting 2% to 8% of pregnancies worldwide, and is an important cause of both maternal and fetal morbidity and mortality. Importantly, although aspirin and calcium are able to prevent preeclampsia in some women, there is no cure apart from delivery of the placenta and fetus, often necessitating iatrogenic preterm birth. Preclinical models of preeclampsia are widely used to investigate the causes and consequences of preeclampsia and to evaluate safety and efficacy of potential preventative and therapeutic interventions. In this review, we provide a summary of the published preclinical models of preeclampsia that meet human diagnostic criteria, including the development of maternal hypertension, together with new-onset proteinuria, maternal organ dysfunction, and uteroplacental dysfunction. We then discuss evidence from preclinical models for multiple causal factors of preeclampsia, including those implicated in early-onset and late-onset preeclampsia. Next, we discuss the impact of exposure to a preeclampsia-like environment for later maternal and progeny health. The presence of long-term impairment, particularly cardiovascular outcomes, in mothers and progeny after an experimentally induced preeclampsia-like pregnancy, implies that later onset or reduced severity of preeclampsia will improve later maternal and progeny health. Finally, we summarize published intervention studies in preclinical models and identify gaps in knowledge that we consider should be targets for future research.

中文翻译:

先兆子痫动物模型

补充数字内容在文本中可用。先兆子痫是一种常见的妊娠并发症,影响全球 2% 至 8% 的妊娠,是导致母婴发病率和死亡率的重要原因。重要的是,虽然阿司匹林和钙能够预防一些女性的先兆子痫,但除了胎盘和胎儿的分娩外,没有其他治疗方法,通常需要医源性早产。先兆子痫的临床前模型被广泛用于调查先兆子痫的原因和后果,并评估潜在预防和治疗干预措施的安全性和有效性。在这篇综述中,我们总结了已发表的符合人类诊断标准的先兆子痫临床前模型,包括母体高血压的发展,以及新发蛋白尿,母体器官功能障碍和子宫胎盘功能障碍。然后,我们讨论了来自先兆子痫的多种因果因素的临床前模型的证据,包括那些与早发性和晚发性先兆子痫有关的因素。接下来,我们讨论暴露于类似先兆子痫的环境对以后母体和后代健康的影响。在实验诱导的先兆子痫样妊娠后,母亲和后代存在长期损害,尤其是心血管结果,这意味着先兆子痫的晚发或减轻严重程度将改善后来的母亲和后代的健康。最后,我们总结了临床前模型中已发表的干预研究,并确定了我们认为应该作为未来研究目标的知识差距。然后,我们讨论了来自先兆子痫的多种因果因素的临床前模型的证据,包括那些与早发性和晚发性先兆子痫有关的因素。接下来,我们讨论暴露于类似先兆子痫的环境对以后母体和后代健康的影响。在实验诱导的先兆子痫样妊娠后,母亲和后代存在长期损害,尤其是心血管结果,这意味着先兆子痫的晚发或减轻严重程度将改善后来的母亲和后代的健康。最后,我们总结了临床前模型中已发表的干预研究,并确定了我们认为应该作为未来研究目标的知识差距。然后,我们讨论了来自先兆子痫的多种因果因素的临床前模型的证据,包括那些与早发性和晚发性先兆子痫有关的因素。接下来,我们讨论暴露于类似先兆子痫的环境对以后母体和后代健康的影响。在实验诱导的先兆子痫样妊娠后,母亲和后代存在长期损害,尤其是心血管结果,这意味着先兆子痫的晚发或减轻严重程度将改善后来的母亲和后代的健康。最后,我们总结了临床前模型中已发表的干预研究,并确定了我们认为应该作为未来研究目标的知识差距。我们讨论了暴露于类似先兆子痫的环境对以后母体和后代健康的影响。在实验诱导的先兆子痫样妊娠后,母亲和后代存在长期损害,尤其是心血管结果,这意味着先兆子痫的晚发或减轻严重程度将改善后来的母亲和后代的健康。最后,我们总结了临床前模型中已发表的干预研究,并确定了我们认为应该作为未来研究目标的知识差距。我们讨论了暴露于类似先兆子痫的环境对以后母体和后代健康的影响。在实验诱导的先兆子痫样妊娠后,母亲和后代存在长期损害,尤其是心血管结果,这意味着先兆子痫的晚发或减轻严重程度将改善后来的母亲和后代的健康。最后,我们总结了临床前模型中已发表的干预研究,并确定了我们认为应该作为未来研究目标的知识差距。意味着先兆子痫的晚发或减轻的严重程度将改善后来的母体和后代的健康。最后,我们总结了临床前模型中已发表的干预研究,并确定了我们认为应该作为未来研究目标的知识差距。意味着先兆子痫的晚发或减轻的严重程度将改善后来的母体和后代的健康。最后,我们总结了临床前模型中已发表的干预研究,并确定了我们认为应该作为未来研究目标的知识差距。
更新日期:2020-06-01
down
wechat
bug